Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
Recruiting · NCT06234397 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors | Advanced or Metastatic Solid Tumors | Recruiting | Phase 1 | 2026-09-25 | NCT06234397 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hanmi Pharmaceutical Company Limited | 15 |
| Merck Sharp & Dohme LLC | 650 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 338 |
| Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center | Cincinnati | United States | 2 |
| Mary Crowley Cancer Research | Dallas | United States | 29 |
| Mays Cancer Center at University of Texas Health San Antonio MD Anderson Cencer Center | San Antonio | United States | 1 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| Samsung Medical Center | Seoul | South Korea | 375 |
| Seoul National University Bundang Hospital | Seongnam-si | South Korea | 107 |
| Seoul National University Hospital | Seoul | South Korea | 393 |
| Severance Hospital | Seoul | South Korea | 81 |
| The START Center for Cancer Care - Midwest | Grand Rapids | United States | 2 |